Clinica Chimica Acta, ISSN 0009-8981, 06/2014, Volume 433, pp. 290 - 296
Biomarkers play an important role for the diagnosis and prognosis of heart failure (HF), a disease with high morbidity and mortality as well as a huge impact...
Heart failure | Aldosterone | Parathyroid hormone | BNP | FGF-23 | Multimarker | VITAMIN-D | SECONDARY HYPERPARATHYROIDISM | CALCIUM PARADOX | LEFT-VENTRICULAR HYPERTROPHY | PARATHYROID-HORMONE ASSAYS | ALL-CAUSE MORTALITY | GROWTH-FACTOR 23 | CARDIOVASCULAR-DISEASES | MEDICAL LABORATORY TECHNOLOGY | CHRONIC KIDNEY-DISEASE | PLASMA-ALDOSTERONE LEVELS | Heart Failure - therapy | Animals | Parathyroid Hormone - metabolism | Humans | Myocardium - metabolism | Heart Failure - diagnosis | Heart Failure - metabolism | Parathyroid Hormone - blood | Heart Failure - blood
Heart failure | Aldosterone | Parathyroid hormone | BNP | FGF-23 | Multimarker | VITAMIN-D | SECONDARY HYPERPARATHYROIDISM | CALCIUM PARADOX | LEFT-VENTRICULAR HYPERTROPHY | PARATHYROID-HORMONE ASSAYS | ALL-CAUSE MORTALITY | GROWTH-FACTOR 23 | CARDIOVASCULAR-DISEASES | MEDICAL LABORATORY TECHNOLOGY | CHRONIC KIDNEY-DISEASE | PLASMA-ALDOSTERONE LEVELS | Heart Failure - therapy | Animals | Parathyroid Hormone - metabolism | Humans | Myocardium - metabolism | Heart Failure - diagnosis | Heart Failure - metabolism | Parathyroid Hormone - blood | Heart Failure - blood
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 07/2016, Volume 311, Issue 1, pp. R104 - R114
Cardiac natriuretic peptides (NP) are involved in cardiorenal regulation and in lipolysis. The NP activity is largely dependent on the ratio between the...
Natriuretic peptide receptors | Insulin resistance | Insulin-induced genes | Lipolysis | PHYSIOLOGY | PHOSPHATIDYLINOSITOL 3-KINASE | insulin-induced genes | PHOSPHOINOSITIDE 3-KINASE | WORTMANNIN | INSULIN | natriuretic peptide receptors | LIPOLYTIC PATHWAY | OBESE-PATIENTS | FAT-CELLS | lipolysis | GENETIC VARIANT | insulin resistance | EXPRESSION | ADIPOSE-TISSUE | Insulin - pharmacology | Natriuresis - drug effects | Natriuretic Peptides - metabolism | Receptors, Atrial Natriuretic Factor - metabolism | Humans | Cells, Cultured | Male | Glucose - pharmacology | Intra-Abdominal Fat - cytology | Adipocytes - drug effects | Receptors, Atrial Natriuretic Factor - antagonists & inhibitors | Insulin - blood | Intra-Abdominal Fat - metabolism | Hypoglycemic Agents - pharmacology | Up-Regulation - drug effects | Signal Transduction - drug effects | Adipocytes - metabolism | Lipids - blood | Heart - drug effects | Female | Aged | Intra-Abdominal Fat - drug effects | Receptors, Atrial Natriuretic Factor - drug effects | Adipose tissues | Physiological research | Fat cells | Research | Natriuretic peptides
Natriuretic peptide receptors | Insulin resistance | Insulin-induced genes | Lipolysis | PHYSIOLOGY | PHOSPHATIDYLINOSITOL 3-KINASE | insulin-induced genes | PHOSPHOINOSITIDE 3-KINASE | WORTMANNIN | INSULIN | natriuretic peptide receptors | LIPOLYTIC PATHWAY | OBESE-PATIENTS | FAT-CELLS | lipolysis | GENETIC VARIANT | insulin resistance | EXPRESSION | ADIPOSE-TISSUE | Insulin - pharmacology | Natriuresis - drug effects | Natriuretic Peptides - metabolism | Receptors, Atrial Natriuretic Factor - metabolism | Humans | Cells, Cultured | Male | Glucose - pharmacology | Intra-Abdominal Fat - cytology | Adipocytes - drug effects | Receptors, Atrial Natriuretic Factor - antagonists & inhibitors | Insulin - blood | Intra-Abdominal Fat - metabolism | Hypoglycemic Agents - pharmacology | Up-Regulation - drug effects | Signal Transduction - drug effects | Adipocytes - metabolism | Lipids - blood | Heart - drug effects | Female | Aged | Intra-Abdominal Fat - drug effects | Receptors, Atrial Natriuretic Factor - drug effects | Adipose tissues | Physiological research | Fat cells | Research | Natriuretic peptides
Journal Article
Heart, ISSN 1355-6037, 08/2009, Volume 95, Issue 16, pp. 1315 - 1319
Background:B-type natriuretic peptide (BNP, nesiritide) has anti-fibrotic, anti-hypertrophic, anti-inflammatory, vasodilating, lusitropic and...
CARDIAC FIBROBLASTS | CARDIAC & CARDIOVASCULAR SYSTEMS | DYSFUNCTION | ATRIAL-NATRIURETIC-PEPTIDE | HEART-FAILURE | Mineralocorticoid Receptor Antagonists - administration & dosage | Humans | Middle Aged | Stroke Volume - drug effects | Male | Natriuretic Peptide, Brain - administration & dosage | Recombinant Proteins - administration & dosage | Myocardial Infarction - drug therapy | Natriuretic Agents - administration & dosage | Female | Myocardial Infarction - physiopathology | Vasodilator Agents - administration & dosage | Ventricular Remodeling - drug effects | Care and treatment | Patient outcomes | Heart ventricles | Physiological aspects | Research | Aldosterone | Heart attack | Natriuretic peptides | Studies | Heart failure | Enzymes | Heart attacks | Peptides | Rodents | Clinical trials | Cardiovascular disease | Trends | Kinases
CARDIAC FIBROBLASTS | CARDIAC & CARDIOVASCULAR SYSTEMS | DYSFUNCTION | ATRIAL-NATRIURETIC-PEPTIDE | HEART-FAILURE | Mineralocorticoid Receptor Antagonists - administration & dosage | Humans | Middle Aged | Stroke Volume - drug effects | Male | Natriuretic Peptide, Brain - administration & dosage | Recombinant Proteins - administration & dosage | Myocardial Infarction - drug therapy | Natriuretic Agents - administration & dosage | Female | Myocardial Infarction - physiopathology | Vasodilator Agents - administration & dosage | Ventricular Remodeling - drug effects | Care and treatment | Patient outcomes | Heart ventricles | Physiological aspects | Research | Aldosterone | Heart attack | Natriuretic peptides | Studies | Heart failure | Enzymes | Heart attacks | Peptides | Rodents | Clinical trials | Cardiovascular disease | Trends | Kinases
Journal Article
Journal of Hypertension, ISSN 0263-6352, 06/2015, Volume 33, p. e304
Journal Article
Circulation, ISSN 0009-7322, 1997, Volume 96, Issue 2, pp. 388 - 390
Heart failure | Editorials | Prognosis | Hormones | Natriuretic peptides | K MA HEMATOLOGY | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | ATRIAL-NATRIURETIC-PEPTIDE | hormones | K ZD PERIPHERAL VASCULAR DISEASE | editorials | RECEPTOR | MODEL | prognosis | natriuretic peptides | K DQ CARDIAC & CARDIOVASCULAR SYSTEMS | DOGS | PERIPHERAL VASCULAR DISEASE | HYPERTENSION | HEMATOLOGY | BRAIN | Heart Failure - diagnosis | Heart Failure - metabolism | Natriuretic Peptide, Brain | Humans | Heart Failure - physiopathology | Nerve Tissue Proteins - urine
Journal Article
Analyst (Cambridge UK), ISSN 0003-2654, 01/2010, Volume 135, Issue 1, pp. 36 - 41
Hydrophobic tagging of biomolecules has been reported by our group and others to increase their ionization efficiency during electrospray ionization and...
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2001, Volume 76, Issue 11, pp. 1111 - 1119
To determine levels of natriuretic peptides (NPs) in patients with end-stage renal disease (ESRD) and to examine the relationship of these cardiovascular...
CAD = coronary artery disease | CNP = C-type natriuretic peptide | LVD = left ventricular systolic dysfunction | AUC = area under the curve | ESRD = end-stage renal disease | DNP = Dendroaspis natriuretic peptide | Kt/V = fractional urea clearance rate | BNP = brain natriuretic peptide | DNP-LI = DNP-like immunoreactivity | PWT = posterior wall thickness | CHF = congestive heart failure | ANP = atrial natriuretic peptide | LVH = left ventricular hypertrophy | NP = natriuretic peptide | LVMI = left ventricular mass index | ROC = receiver operating characteristic | IVST = intraventricular septum thickness | LVEF = left ventricular ejection fraction | MI = myocardial infarction | MORTALITY | HYPERTROPHY | POPULATION | MEDICINE, GENERAL & INTERNAL | INDEPENDENT PREDICTOR | PLASMA | MORBIDITY | HEART-FAILURE | HEMODIALYSIS-PATIENTS | INDICATOR | DYSFUNCTION | Hypertrophy, Left Ventricular - blood | Comorbidity | Humans | Middle Aged | Risk Factors | Linear Models | Male | Natriuretic Peptide, Brain - physiology | Atrial Natriuretic Factor - blood | Case-Control Studies | Kidney Failure, Chronic - blood | Adolescent | Aged, 80 and over | Biomarkers | Adult | Female | ROC Curve | Aged | Hemodynamics | Natriuretic Peptide, Brain - blood | Kidney Failure, Chronic - etiology | Renal Dialysis
CAD = coronary artery disease | CNP = C-type natriuretic peptide | LVD = left ventricular systolic dysfunction | AUC = area under the curve | ESRD = end-stage renal disease | DNP = Dendroaspis natriuretic peptide | Kt/V = fractional urea clearance rate | BNP = brain natriuretic peptide | DNP-LI = DNP-like immunoreactivity | PWT = posterior wall thickness | CHF = congestive heart failure | ANP = atrial natriuretic peptide | LVH = left ventricular hypertrophy | NP = natriuretic peptide | LVMI = left ventricular mass index | ROC = receiver operating characteristic | IVST = intraventricular septum thickness | LVEF = left ventricular ejection fraction | MI = myocardial infarction | MORTALITY | HYPERTROPHY | POPULATION | MEDICINE, GENERAL & INTERNAL | INDEPENDENT PREDICTOR | PLASMA | MORBIDITY | HEART-FAILURE | HEMODIALYSIS-PATIENTS | INDICATOR | DYSFUNCTION | Hypertrophy, Left Ventricular - blood | Comorbidity | Humans | Middle Aged | Risk Factors | Linear Models | Male | Natriuretic Peptide, Brain - physiology | Atrial Natriuretic Factor - blood | Case-Control Studies | Kidney Failure, Chronic - blood | Adolescent | Aged, 80 and over | Biomarkers | Adult | Female | ROC Curve | Aged | Hemodynamics | Natriuretic Peptide, Brain - blood | Kidney Failure, Chronic - etiology | Renal Dialysis
Journal Article
The Lancet, ISSN 0140-6736, 05/1993, Volume 341, Issue 8853, pp. 1105 - 1109
Early identification of patients with symptomless left-ventricular dysfunction and early pharmacologic intervention may have an impact on the outlook of...
MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CONGESTIVE-HEART-FAILURE | FACTOR PROHORMONE | Prospective Studies | Ventricular Function, Left | Humans | Middle Aged | Male | Radionuclide Angiography | Atrial Natriuretic Factor - blood | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Aged | Heart Failure - diagnosis | Heart Failure - diagnostic imaging | Measurement | Congestive heart failure | Diagnosis | Natriuretic peptides | Medical research | Cardiovascular disease | Hormones | Heart failure | Heart | Medical imaging | Angiography | Peptides | Radioisotopes | Pharmacology | Atrial natriuretic peptide | Ventricle | Patients | Beta blockers
MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | CONGESTIVE-HEART-FAILURE | FACTOR PROHORMONE | Prospective Studies | Ventricular Function, Left | Humans | Middle Aged | Male | Radionuclide Angiography | Atrial Natriuretic Factor - blood | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Aged | Heart Failure - diagnosis | Heart Failure - diagnostic imaging | Measurement | Congestive heart failure | Diagnosis | Natriuretic peptides | Medical research | Cardiovascular disease | Hormones | Heart failure | Heart | Medical imaging | Angiography | Peptides | Radioisotopes | Pharmacology | Atrial natriuretic peptide | Ventricle | Patients | Beta blockers
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2000, Volume 75, Issue 4, pp. 337 - 339
Journal Article
Hypertension, ISSN 0194-911X, 2001, Volume 37, Issue 4, pp. 1179 - 1183
Animal studies have demonstrated that CNP causes endothelium-independent vasodilation, which is limited by neutral endopeptidase (NEP) activity. However, the...
Tetraethylammonium chloride | Endopeptidase | Nitric oxide | Hyperpolarizing factor | Natriuretic peptides | nitric oxide | hyperpolarizing factor | ENDOPEPTIDASE-24.11 | PORCINE CORONARY-ARTERIES | tetraethylammonium chloride | HUMAN ENDOTHELIAL-CELLS | natriuretic peptides | INHIBITION | endopeptidase | IN-VIVO | PERIPHERAL VASCULAR DISEASE | EXPRESSION | SMOOTH-MUSCLE CELLS | Humans | Nitric Oxide Synthase - antagonists & inhibitors | Nitric Oxide Synthase - physiology | Biological Availability | Nitric Oxide - physiology | Natriuretic Peptide, C-Type - physiology | Neprilysin - metabolism | Vascular Resistance - physiology | Cyclooxygenase Inhibitors - pharmacology | Epoprostenol - antagonists & inhibitors | Epoprostenol - physiology | Potassium Channels - metabolism | Analysis of Variance | Adolescent | Forearm - blood supply | Neprilysin - antagonists & inhibitors | Adult | Potassium Channel Blockers | Vasodilation - drug effects | Vasodilation - physiology | Prostaglandin-Endoperoxide Synthases - physiology
Tetraethylammonium chloride | Endopeptidase | Nitric oxide | Hyperpolarizing factor | Natriuretic peptides | nitric oxide | hyperpolarizing factor | ENDOPEPTIDASE-24.11 | PORCINE CORONARY-ARTERIES | tetraethylammonium chloride | HUMAN ENDOTHELIAL-CELLS | natriuretic peptides | INHIBITION | endopeptidase | IN-VIVO | PERIPHERAL VASCULAR DISEASE | EXPRESSION | SMOOTH-MUSCLE CELLS | Humans | Nitric Oxide Synthase - antagonists & inhibitors | Nitric Oxide Synthase - physiology | Biological Availability | Nitric Oxide - physiology | Natriuretic Peptide, C-Type - physiology | Neprilysin - metabolism | Vascular Resistance - physiology | Cyclooxygenase Inhibitors - pharmacology | Epoprostenol - antagonists & inhibitors | Epoprostenol - physiology | Potassium Channels - metabolism | Analysis of Variance | Adolescent | Forearm - blood supply | Neprilysin - antagonists & inhibitors | Adult | Potassium Channel Blockers | Vasodilation - drug effects | Vasodilation - physiology | Prostaglandin-Endoperoxide Synthases - physiology
Journal Article
Proceedings of the Association of American Physicians, ISSN 1081-650X, 1999, Volume 111, Issue 5, pp. 406 - 416
The natriuretic peptides are a group of structurally similar but genetically distinct peptides that have diverse actions in cardiovascular, renal, and...
Hormone | 3',5'-cyclic guanosine monophosphate | Ventricular dysfunction | Kidney | Markers | Neutral endopeptidase inhibition | MEDICINE, RESEARCH & EXPERIMENTAL | 3 ',5 '-cyclic guanosine monophosphate | MYOCARDIAL-INFARCTION | CONVERTING-ENZYME-INHIBITION | neutral endopeptidase inhibition | ventricular dysfunction | ANGIOTENSIN-II | DILATED CARDIOMYOPATHY | hormone | kidney | MEDICINE, GENERAL & INTERNAL | INTRAVENOUS-INJECTION | LEFT-VENTRICULAR DYSFUNCTION | EXPERIMENTAL-HYPERTENSION | markers | SMOOTH-MUSCLE CELLS | RENAL RESPONSE | Amino Acid Sequence | Natriuretic Peptide, Brain - therapeutic use | Natriuretic Peptide, Brain - genetics | Prognosis | Atrial Natriuretic Factor - metabolism | Humans | Natriuretic Peptide, Brain - metabolism | Molecular Sequence Data | Heart Failure - metabolism | Neprilysin - metabolism | Enzyme Inhibitors - therapeutic use | Heart Failure - drug therapy | Ventricular Dysfunction, Left - metabolism | Animals | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Natriuretic Peptide, C-Type - metabolism | Atrial Natriuretic Factor - genetics | Neprilysin - antagonists & inhibitors | Natriuretic Peptide, C-Type - genetics | Heart Failure - diagnosis
Hormone | 3',5'-cyclic guanosine monophosphate | Ventricular dysfunction | Kidney | Markers | Neutral endopeptidase inhibition | MEDICINE, RESEARCH & EXPERIMENTAL | 3 ',5 '-cyclic guanosine monophosphate | MYOCARDIAL-INFARCTION | CONVERTING-ENZYME-INHIBITION | neutral endopeptidase inhibition | ventricular dysfunction | ANGIOTENSIN-II | DILATED CARDIOMYOPATHY | hormone | kidney | MEDICINE, GENERAL & INTERNAL | INTRAVENOUS-INJECTION | LEFT-VENTRICULAR DYSFUNCTION | EXPERIMENTAL-HYPERTENSION | markers | SMOOTH-MUSCLE CELLS | RENAL RESPONSE | Amino Acid Sequence | Natriuretic Peptide, Brain - therapeutic use | Natriuretic Peptide, Brain - genetics | Prognosis | Atrial Natriuretic Factor - metabolism | Humans | Natriuretic Peptide, Brain - metabolism | Molecular Sequence Data | Heart Failure - metabolism | Neprilysin - metabolism | Enzyme Inhibitors - therapeutic use | Heart Failure - drug therapy | Ventricular Dysfunction, Left - metabolism | Animals | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Natriuretic Peptide, C-Type - metabolism | Atrial Natriuretic Factor - genetics | Neprilysin - antagonists & inhibitors | Natriuretic Peptide, C-Type - genetics | Heart Failure - diagnosis
Journal Article
Journal of Neurosurgery, ISSN 0022-3085, 2001, Volume 94, Issue 2, pp. 252 - 256
Object. Natriuresis is a common systemic manifestation of aneurysmal subarachnoid hemorrhage (SAH). Natriuresis and its accompanying hypovolemia may be a major...
Adrenomedullin | Brain natriuretic factor cerebral vasospasm | Subarachnoid hemorrhage | Atrial natriuretic factor | SURGERY | adrenomedullin | subarachnoid hemorrhage | atrial natriuretic factor | brain natriuretic factor | ENDOTHELIN | cerebral vasospasm | CLINICAL NEUROLOGY | Peptides - blood | Intracranial Aneurysm - blood | Vasospasm, Intracranial - blood | Vasospasm, Intracranial - surgery | Humans | Middle Aged | Natriuretic Agents - blood | Male | Reference Values | Intracranial Aneurysm - diagnosis | Intracranial Aneurysm - surgery | Vasospasm, Intracranial - diagnosis | Aged, 80 and over | Adult | Female | Aged | Subarachnoid Hemorrhage - diagnosis | Vasodilation - physiology | Subarachnoid Hemorrhage - blood | Subarachnoid Hemorrhage - surgery
Adrenomedullin | Brain natriuretic factor cerebral vasospasm | Subarachnoid hemorrhage | Atrial natriuretic factor | SURGERY | adrenomedullin | subarachnoid hemorrhage | atrial natriuretic factor | brain natriuretic factor | ENDOTHELIN | cerebral vasospasm | CLINICAL NEUROLOGY | Peptides - blood | Intracranial Aneurysm - blood | Vasospasm, Intracranial - blood | Vasospasm, Intracranial - surgery | Humans | Middle Aged | Natriuretic Agents - blood | Male | Reference Values | Intracranial Aneurysm - diagnosis | Intracranial Aneurysm - surgery | Vasospasm, Intracranial - diagnosis | Aged, 80 and over | Adult | Female | Aged | Subarachnoid Hemorrhage - diagnosis | Vasodilation - physiology | Subarachnoid Hemorrhage - blood | Subarachnoid Hemorrhage - surgery
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 11/1994, Volume 205, Issue 1, pp. 765 - 771
C-type natriuretic (CNP) caused concentration-dependent relaxations in porcine coronary arteries with a maximal relaxation (10(-6)M) of 46%. Relaxations to CNP...
ACTIVATION | PLASMA | BIOPHYSICS | MECHANISM | CNP | POTASSIUM CHANNELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION | RECEPTOR | CA-2+-ACTIVATED K+-CHANNELS | Membrane Potentials - drug effects | Coronary Vessels - drug effects | Coronary Vessels - physiology | Potassium Channels - physiology | Arteries - drug effects | Muscle, Smooth, Vascular - cytology | Potassium Channels - drug effects | Natriuretic Peptide, C-Type | Animals | Arteries - physiology | Swine | Proteins - pharmacology | Atrial Natriuretic Factor - pharmacology | Muscle Relaxation - drug effects | In Vitro Techniques | Muscle, Smooth, Vascular - physiology | Muscle, Smooth, Vascular - drug effects
ACTIVATION | PLASMA | BIOPHYSICS | MECHANISM | CNP | POTASSIUM CHANNELS | BIOCHEMISTRY & MOLECULAR BIOLOGY | ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION | RECEPTOR | CA-2+-ACTIVATED K+-CHANNELS | Membrane Potentials - drug effects | Coronary Vessels - drug effects | Coronary Vessels - physiology | Potassium Channels - physiology | Arteries - drug effects | Muscle, Smooth, Vascular - cytology | Potassium Channels - drug effects | Natriuretic Peptide, C-Type | Animals | Arteries - physiology | Swine | Proteins - pharmacology | Atrial Natriuretic Factor - pharmacology | Muscle Relaxation - drug effects | In Vitro Techniques | Muscle, Smooth, Vascular - physiology | Muscle, Smooth, Vascular - drug effects
Journal Article
Science, ISSN 0036-8075, 3/1986, Volume 231, Issue 4742, pp. 1145 - 1147
A sensitive radioimmunoassay for atrial natriuretic peptide was used to examine the relation between circulating atrial natriuretic peptide and cardiac filling...
Heart | Human experimentation | Antiserum | Sodium | Radioimmunoassay | Antibodies | Reports | Congestive heart failure | Cardiovascular diseases | Natriuretic peptides | Blood plasma | Humans | Middle Aged | Cardiovascular Diseases - blood | Adult | Female | Male | Aged | Hemodynamics | Heart Failure - blood | Atrial Natriuretic Factor - blood | Physiological aspects | Human physiology | Research | Peptides
Heart | Human experimentation | Antiserum | Sodium | Radioimmunoassay | Antibodies | Reports | Congestive heart failure | Cardiovascular diseases | Natriuretic peptides | Blood plasma | Humans | Middle Aged | Cardiovascular Diseases - blood | Adult | Female | Male | Aged | Hemodynamics | Heart Failure - blood | Atrial Natriuretic Factor - blood | Physiological aspects | Human physiology | Research | Peptides
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/1991, Volume 325, Issue 14, pp. 997 - 1001
ATHEROSCLEROSIS may be initiated by endothelial injury, which then leads to the proliferation of intimal smooth-muscle cells. 1 The atherogenic smooth-muscle...
PATHOGENESIS | RESPONSES | MEDICINE, GENERAL & INTERNAL | ARTERIES | ANGINA | DISEASE | PROLIFERATION | PRIMATES | SMOOTH-MUSCLE CELLS | INCREASED PLASMA ENDOTHELIN | Physiological aspects | Development and progression | Endothelin | Atherosclerosis | Cell proliferation | Coronary artery | Smooth muscle | Endothelin 1 | Endothelial cells | Endothelium | Vascular diseases | Arteriosclerosis | Aorta | Immunoreactivity | Growth factors | Heart diseases | Plasma | Hypotheses | Heart attacks | Medical imaging | Cardiovascular disease | Metabolic disorders
PATHOGENESIS | RESPONSES | MEDICINE, GENERAL & INTERNAL | ARTERIES | ANGINA | DISEASE | PROLIFERATION | PRIMATES | SMOOTH-MUSCLE CELLS | INCREASED PLASMA ENDOTHELIN | Physiological aspects | Development and progression | Endothelin | Atherosclerosis | Cell proliferation | Coronary artery | Smooth muscle | Endothelin 1 | Endothelial cells | Endothelium | Vascular diseases | Arteriosclerosis | Aorta | Immunoreactivity | Growth factors | Heart diseases | Plasma | Hypotheses | Heart attacks | Medical imaging | Cardiovascular disease | Metabolic disorders
Journal Article
Circulation, ISSN 0009-7322, 1993, Volume 88, Issue 3, pp. 1004 - 1009
Background. Atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) are a family of structurally related...
heart failure | natriuretic peptides | left ventricle | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | NATRIURETIC PEPTIDES | HEART FAILURE | ATRIAL | RATS | RECEPTOR | INFUSION | RESPONSES | LEFT VENTRICLE | GENE | PLASMA-LEVELS | ENDOTHELIAL-CELLS | PERIPHERAL VASCULAR DISEASE | EXPRESSION | Myocardium - chemistry | Humans | Middle Aged | Nerve Tissue Proteins - analysis | Male | Heart Failure - metabolism | Heart Ventricles - chemistry | Natriuretic Peptide, C-Type | Natriuretic Peptide, Brain | Radioimmunoassay | Female | Atrial Natriuretic Factor - analysis | Heart Atria - chemistry
heart failure | natriuretic peptides | left ventricle | ACTIVATION | CARDIAC & CARDIOVASCULAR SYSTEMS | NATRIURETIC PEPTIDES | HEART FAILURE | ATRIAL | RATS | RECEPTOR | INFUSION | RESPONSES | LEFT VENTRICLE | GENE | PLASMA-LEVELS | ENDOTHELIAL-CELLS | PERIPHERAL VASCULAR DISEASE | EXPRESSION | Myocardium - chemistry | Humans | Middle Aged | Nerve Tissue Proteins - analysis | Male | Heart Failure - metabolism | Heart Ventricles - chemistry | Natriuretic Peptide, C-Type | Natriuretic Peptide, Brain | Radioimmunoassay | Female | Atrial Natriuretic Factor - analysis | Heart Atria - chemistry
Journal Article
AJP - Renal Physiology, ISSN 0363-6127, 04/1995, Volume 268, Issue 4, pp. 657 - F663
M. Jougasaki, C. M. Wei, L. L. Aarhus, D. M. Heublein, S. M. Sandberg and J. C. Burnett Jr Cardiorenal Research Laboratory, Mayo Clinic and Foundation,...
Immunohistochemistry | Sodium excretion | Distal tubular function | guanosine 3',5'-cyclic monophosphate | Natriuretic peptide | Guanosine 3′,5′-cyclic monophosphate | Dose-Response Relationship, Drug | Tissue Distribution | Kidney - metabolism | Animals | Kidney - drug effects | Natriuretic Agents - physiology | Peptides - physiology | Dogs | Adrenomedullin | Kidney - cytology | Peptides - pharmacology | Regulation | Natriuresis | Research | Peptide hormones | Methods
Immunohistochemistry | Sodium excretion | Distal tubular function | guanosine 3',5'-cyclic monophosphate | Natriuretic peptide | Guanosine 3′,5′-cyclic monophosphate | Dose-Response Relationship, Drug | Tissue Distribution | Kidney - metabolism | Animals | Kidney - drug effects | Natriuretic Agents - physiology | Peptides - physiology | Dogs | Adrenomedullin | Kidney - cytology | Peptides - pharmacology | Regulation | Natriuresis | Research | Peptide hormones | Methods
Journal Article
Circulation, ISSN 0009-7322, 1992, Volume 86, Issue 6, pp. III12 - III19
The endothelium possesses the ability to modulate vascular tone by the release of vasodilator and vasoconstrictor substances, among them endothelium-derived...
Endothelium-derived relaxing factor | Vascular resistance | Endothelin | CANINE FEMORAL-ARTERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RELAXING FACTOR | HEART-FAILURE | DEPENDENT VASCULAR RELAXATION | VASCULAR RESISTANCE | CORONARY-ARTERIES | OXIDE-GENERATING VASODILATORS | ENDOTHELIUM-DERIVED RELAXING FACTOR | L-ARGININE | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | ESSENTIAL-HYPERTENSION | ENDOTHELIN | SMOOTH-MUSCLE CELLS | Myocardial Ischemia - metabolism | Endothelins - physiology | Endothelins - pharmacology | Humans | Arteriosclerosis - physiopathology | Nitric Oxide - physiology | Endothelium, Vascular - physiology | Animals | Endothelium, Vascular - metabolism | Vasomotor System - physiology | Dogs | Myocardial Ischemia - physiopathology | Arteriosclerosis - metabolism | Nitric Oxide - metabolism
Endothelium-derived relaxing factor | Vascular resistance | Endothelin | CANINE FEMORAL-ARTERY | CARDIAC & CARDIOVASCULAR SYSTEMS | RELAXING FACTOR | HEART-FAILURE | DEPENDENT VASCULAR RELAXATION | VASCULAR RESISTANCE | CORONARY-ARTERIES | OXIDE-GENERATING VASODILATORS | ENDOTHELIUM-DERIVED RELAXING FACTOR | L-ARGININE | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | ESSENTIAL-HYPERTENSION | ENDOTHELIN | SMOOTH-MUSCLE CELLS | Myocardial Ischemia - metabolism | Endothelins - physiology | Endothelins - pharmacology | Humans | Arteriosclerosis - physiopathology | Nitric Oxide - physiology | Endothelium, Vascular - physiology | Animals | Endothelium, Vascular - metabolism | Vasomotor System - physiology | Dogs | Myocardial Ischemia - physiopathology | Arteriosclerosis - metabolism | Nitric Oxide - metabolism
Journal Article